Jasper Stock Analysis

JSPR -  USA Stock  

USD 4.54  0.32  6.58%

The big decline in price over the last few months for Jasper Therapeuticsmay raise some interest from retail investors. The stock closed today at a share price of 4.54 on 70,319 in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Jasper Therapeutics or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.0. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Jasper Therapeutics partners.
Please see Risk vs Return Analysis.

Jasper Stock Analysis 

 
Refresh
The Jasper Therapeutics stock analysis report makes it easy to digest most publicly released information about Jasper Therapeutics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Jasper Stock analysis module also helps to analyze the Jasper Therapeutics price relationship with some important fundamental indicators such as market cap and management efficiency.

Jasper Stock Analysis Notes

About 60.0% of the company shares are held by company insiders. The book value of Jasper Therapeutics was currently reported as 2.01. The company recorded a loss per share of 0.81. Jasper Therapeutics had not issued any dividends in recent years. Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. Jasper Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. To learn more about Jasper Therapeutics call the company at 650 549 1400 or check out https://jaspertherapeutics.com.

Jasper Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Jasper Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Jasper Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Jasper Therapeutics generated a negative expected return over the last 90 days
Jasper Therapeutics has high historical volatility and very poor performance
Net Loss for the year was (31.57 M).
Jasper Therapeutics currently holds about 100.91 M in cash with (24.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.67.
Jasper Therapeutics has a frail financial position based on the latest SEC disclosures
Roughly 60.0% of the company shares are held by company insiders
Latest headline from simplywall.st: Private equity firms among Jasper Therapeutics, Inc.s largest stockholders and were hit after last weeks 11 percent price drop - Simply Wall St

Jasper Therapeutics Upcoming and Recent Events

Earnings reports are used by Jasper Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Jasper Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report11th of February 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End11th of February 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Jasper Therapeutics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Jasper Therapeutics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Jasper Therapeutics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Jasper Therapeutics specific information freely available to individual and institutional investors to make a timely investment decision.
12th of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
29th of October 2021
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
4th of October 2021
Unclassified Corporate Event. Unclassified Corporate Event
View
1st of October 2021
Unclassified Corporate Event
View
22nd of September 2021
Financial Statements and Exhibits. Other Events. Submission of Matters to a Vote of Security Holders
View
20th of September 2021
Financial Statements and Exhibits. Other Events
View
17th of September 2021
Unclassified Corporate Event
View
9th of September 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
View

Jasper Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Jasper Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Jasper Therapeutics backward and forwards among themselves. Jasper Therapeutics' institutional investor refers to the entity that pools money to purchase Jasper Therapeutics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Meritech Capital Associates V LlcCommon Shares2.5 M134.9 M
Abingworth LlpCommon Shares5.6 M58 M
Citadel Advisors LlcCommon SharesM29.2 M
Federated Hermes IncCommon Shares1.5 M12.5 M
Morgan StanleyCommon Shares108.9 K1.1 M
Owl Creek Asset Management LpWarrants672.1 K995 K
Leverage Partners Absolute Return Fund SpcCommon Shares15 K815 K
Marshall Wace LlpCall Options35 K359 K
Jane Street Group LlcCommon Shares26 K267 K
Note, although Jasper Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Jasper Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 218.41 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jasper Therapeutics's market, we take the total number of its shares issued and multiply it by Jasper Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Jasper Profitablity

Jasper Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Jasper Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Jasper Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Jasper Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Jasper Therapeutics' profitability requires more research than a typical breakdown of Jasper Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Average Assets(0.35) (0.37) 
Return on Average Equity 5.66  5.63 
Return on Invested Capital(0.38) (0.41) 

Management Efficiency

As of 01/21/2022, Return on Average Assets is likely to drop to -0.37. In addition to that, Return on Average Equity is likely to drop to 5.63. Jasper Therapeutics Total Assets are relatively stable at the moment as compared to the past year. Jasper Therapeutics reported last year Total Assets of 21.02 Million. As of 01/21/2022, Current Assets is likely to grow to about 19.9 M, while Return on Average Assets are likely to drop (0.37) . Jasper Therapeutics management efficiency ratios could be used to measure how well jasper therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2022
Book Value per Share(5.16) (5.57) 
Enterprise Value over EBIT(4.60) (4.96) 
Enterprise Value over EBITDA(4.54) (4.89) 
Price to Book Value(4.10) (4.42) 
Tangible Assets Book Value per Share 3.43  3.88 
Enterprise Value111.9 M111.6 M
Tangible Asset Value21 M21.7 M

Technical Drivers

As of the 21st of January, Jasper Therapeutics retains the risk adjusted performance of (0.21), and Market Risk Adjusted Performance of (2.76). Jasper Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Jasper Therapeutics, which can be compared to its competitors. Please check out Jasper Therapeutics variance and potential upside to decide if Jasper Therapeutics is priced fairly, providing market reflects its last-minute price of 4.54 per share. Given that Jasper Therapeutics has jensen alpha of (1.38), we strongly advise you to confirm Jasper Therapeutics's regular market performance to make sure the company can sustain itself at a future point.

Jasper Therapeutics Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Jasper Therapeutics price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average. View also all equity analysis or get more info about triple exponential moving average t3 overlap studies indicator.

Jasper Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Jasper Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Jasper Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Jasper Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Jasper Therapeutics Predictive Daily Indicators

Jasper Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Jasper Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Jasper Therapeutics Forecast Models

Jasper Therapeutics time-series forecasting models is one of many Jasper Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jasper Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Jasper Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Jasper Therapeutics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jasper shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Jasper Therapeutics. By using and applying Jasper Stock analysis, traders can create a robust methodology for identifying Jasper entry and exit points for their positions.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. Jasper Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.

Current Jasper Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Jasper analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Jasper analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
20.0Strong Buy2Odds
Jasper Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Jasper analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Jasper stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Jasper Therapeutics, talking to its executives and customers, or listening to Jasper conference calls.
Jasper Analyst Advice Details

Jasper Stock Analysis Indicators

Jasper Therapeutics stock analysis indicators help investors evaluate how Jasper Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Jasper Therapeutics shares will generate the highest return on investment. By understating and applying Jasper Therapeutics stock analysis, traders can identify Jasper Therapeutics position entry and exit signals to maximize returns.
Shares Percent Shares Out1.10%
Quick Ratio11.05
Fifty Two Week Low5.73
Forward Price Earnings-4.85
Float Shares7.02M
Fifty Two Week High18.88
Shares Short Prior Month184.51k
Average Daily Volume Last 10 Day85.77k
Average Daily Volume In Three Month422.2k
Fifty Day Average8.27
Two Hundred Day Average9.68
Please see Risk vs Return Analysis. Note that the Jasper Therapeutics information on this page should be used as a complementary analysis to other Jasper Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Jasper Stock analysis

When running Jasper Therapeutics price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Is Jasper Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jasper Therapeutics. If investors know Jasper will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jasper Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Jasper Therapeutics is measured differently than its book value, which is the value of Jasper that is recorded on the company's balance sheet. Investors also form their own opinion of Jasper Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Jasper Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jasper Therapeutics' market value can be influenced by many factors that don't directly affect Jasper Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jasper Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Jasper Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jasper Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.